Quality of Life in Patients with Vitiligo

Overview

Journal Health Qual Life Outcomes

Publisher Biomed Central

Specialty Public Health

Date 2003 Nov 14

PMID 14613564

Citations 62

Authors

Davinder Parsad

Sunil Dogra

Amrinder Jit Kanwar

Affiliations

Soon will be listed here.

Abstract

Vitiligo is an important skin disease having major impact on quality of life of patients, many of whom feel distressed and stigmatized by their condition. Society greets vitiligo patients in much the same way as it does any one else who appears to be different. They are started at or subjected to whispered comments, antagonism, insult or isolation. The chronic nature of disease, long term treatment, lack of uniform effective therapy and unpredictable course of disease is usually very demoralizing for patients suffering from vitiligo. It is important to recognize and deal with psychological components of this disease to improve their quality of life and to obtain a better treatment response.

Citing Articles

Efficacy of non-cultured non-trypsinized dermabraded epidermal cell graft followed by narrowband ultraviolet B phototherapy in stable vitiligo.

Chugh D, Kolalapudi S, Praveen S, Konala S, Swetha N, Reddy M J Cutan Aesthet Surg. 2025; 18(1):48-55.

PMID: 40027532 PMC: 11866696. DOI: 10.25259/JCAS_116_2024.

Topical Tacrolimus in Vitiligo: Consensus Paper from the Pigmentary Disorders Society.

Sarkar R, Dogra S, Vinay K, Sinha S, Narayan V, Kumaran M Clin Cosmet Investig Dermatol. 2024; 17:2875-2886.

PMID: 39717835 PMC: 11664111. DOI: 10.2147/CCID.S455602.

Determining the Mean Dermatology Life Quality Index of Skin of Color (SOC) Patients With Vitiligo: A South Asian Perspective.

Habib A, Aslam H, Muhammad A, Mahajan A, Muhammad S, Ghafar R Cureus. 2024; 16(10):e70709.

PMID: 39493193 PMC: 11530142. DOI: 10.7759/cureus.70709.

Hybrid high and low molecular weight chains of hyaluronan for clitoral injection is an effective modality treatment for increasing female sexual satisfaction: an interventional, randomized-controlled parallel study.

Atef L, Mohammed G, Al-Dhubaibi M, Soliman M, Bahaj S, Saleh Y Sex Med. 2024; 12(5):qfae067.

PMID: 39360229 PMC: 11443283. DOI: 10.1093/sexmed/qfae067.

Evaluation of neutrophil activation marker in patients with vitiligo.

El-Sadek H, Elmadbouly A, Risha B Ir J Med Sci. 2024; 193(6):2797-2802.

PMID: 39186193 PMC: 11666612. DOI: 10.1007/s11845-024-03777-4.

References

Weiss M, Doongaji D, Siddhartha S, Wypij D, Pathare S, Bhatawdekar M . The Explanatory Model Interview Catalogue (EMIC). Contribution to cross-cultural research methods from a study of leprosy and mental health. Br J Psychiatry. 1992; 160:819-30. DOI: 10.1192/bjp.160.6.819. View

Porter J, Beuf A, LERNER A, Nordlund J . The effect of vitiligo on sexual relationships. J Am Acad Dermatol. 1990; 22(2 Pt 1):221-2. DOI: 10.1016/0190-9622(90)70028-g. View

AlAbadie M, Kent G, Gawkrodger D . The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol. 1994; 130(2):199-203. DOI: 10.1111/j.1365-2133.1994.tb02900.x. View

Finlay A, Khan G . Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994; 19(3):210-6. DOI: 10.1111/j.1365-2230.1994.tb01167.x. View

Salzer B, Schallreuter K . Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology. 1995; 190(2):109-15. DOI: 10.1159/000246657. View

Ginsburg I . The psychosocial impact of skin disease. An overview. Dermatol Clin. 1996; 14(3):473-84. DOI: 10.1016/s0733-8635(05)70375-2. View

Kent G . Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol. 1996; 21(5):330-3. View

Cotterill J, Cunliffe W . Suicide in dermatological patients. Br J Dermatol. 1997; 137(2):246-50. DOI: 10.1046/j.1365-2133.1997.18131897.x. View

Papadopoulos L, Bor R, Legg C . Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol. 1999; 72(3):385-96. DOI: 10.1348/000711299160077. View

10.

LERNER A . Vitiligo. J Invest Dermatol. 1959; 32(2, Part 2):285-310. View

11.

Handa S, Kaur I . Vitiligo: clinical findings in 1436 patients. J Dermatol. 1999; 26(10):653-7. DOI: 10.1111/j.1346-8138.1999.tb02067.x. View

12.

Mattoo S, Handa S, Kaur I, Gupta N, Malhotra R . Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol. 2002; 16(6):573-8. DOI: 10.1046/j.1468-3083.2002.00590.x. View

13.

Parsad D, Pandhi R, Dogra S, Kanwar A, Kumar B . Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol. 2003; 148(2):373-4. DOI: 10.1046/j.1365-2133.2003.05097_9.x. View

14.

Handa S, Dogra S . Epidemiology of childhood vitiligo: a study of 625 patients from north India. Pediatr Dermatol. 2003; 20(3):207-10. DOI: 10.1046/j.1525-1470.2003.20304.x. View

15.

LERNER A, Nordlund J . Vitiligo. What is it? Is it important?. JAMA. 1978; 239(12):1183-7. DOI: 10.1001/jama.239.12.1183. View

16.

Porter J . Children coping with impaired appearance: social and psychologic influences. Gen Hosp Psychiatry. 1984; 6(4):294-301. DOI: 10.1016/0163-8343(84)90024-0. View

17.

Bolognia J, Pawelek J . Biology of hypopigmentation. J Am Acad Dermatol. 1988; 19(2 Pt 1):217-55. DOI: 10.1016/s0190-9622(88)70168-1. View

18.

Savin J . The hidden face of dermatology. Clin Exp Dermatol. 1993; 18(5):393-5. DOI: 10.1111/j.1365-2230.1993.tb02234.x. View